NFLX:NASDAQ
Netflix, Inc.
Data as of 2026-03-09 - not real-time
$97.54
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Netflix (NFLX) is trading at $97.5, comfortably above its 20‑day ($85.7) and 50‑day ($86.8) moving averages but still below the 200‑day average ($109.6), signaling short‑term strength within a longer‑term bearish backdrop. The stock’s RSI sits at 69, nearing overbought territory, while a bullish MACD histogram (+2.26) and rising volume underscore recent momentum. Fundamentally, the company posted 17.6% revenue growth, a 48.5% gross margin and a stellar 42.8% ROE, with forward earnings expected to lift the forward P/E to 25.4.
Recent headlines highlight management’s decision to abandon the Warner Bros. acquisition, a move that investors have praised for preserving balance‑sheet discipline and sharpening focus on organic growth and advertising. The market sentiment is extremely bullish (Fear & Greed Index “Extreme Greed”), and analysts collectively rate the stock as a “Buy” with a median price target of $112, implying roughly a 15% upside from current levels.
Recent headlines highlight management’s decision to abandon the Warner Bros. acquisition, a move that investors have praised for preserving balance‑sheet discipline and sharpening focus on organic growth and advertising. The market sentiment is extremely bullish (Fear & Greed Index “Extreme Greed”), and analysts collectively rate the stock as a “Buy” with a median price target of $112, implying roughly a 15% upside from current levels.
Trading Recommendations
Short Term
< 1 yearbuy
Conviction: 7/10
Key Factors
- Bullish MACD and increasing volume
- Positive market reaction to deal‑discipline decision
- Price approaching key resistance at $100.2
Medium Term
1–3 yearsbuy
Conviction: 8/10
Key Factors
- Strong revenue growth and high ROE
- Forward earnings expansion lowering P/E
- Analyst consensus targets around $112
Long Term
> 3 yearshold
Conviction: 6/10
Key Factors
- Price still below 200‑day average indicating long‑term bearish bias
- High valuation multiples relative to industry peers
- Need for sustained subscriber and ad revenue growth amid competitive pressures
Key Metrics & Analysis
Financial Health
Revenue Growth17.60%
Profit Margin24.30%
P/E Ratio38.6
ROE42.76%
ROA15.25%
Debt/Equity63.78
P/B Ratio15.5
Op. Cash Flow$10.1B
Free Cash Flow$24.8B
Industry P/E18.1
Technical Analysis
TrendBearish
RSI69.4
Support$75.01
Resistance$100.19
MA 20$85.67
MA 50$86.84
MA 200$109.57
MACDBullish
VolumeIncreasing
Fear & Greed Index100
Valuation
Fair Value$166.39
Target Price$113.12
Upside/Downside15.98%
GradeFair
TypeGrowth
Risk Assessment
Beta0.72
Volatility50.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
More Tickers
This analysis may contain inaccuracies. Not financial advice. Always do your own research before making any investment decisions.